|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2818 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/2878 | (2013.01) | ||
| A61K2039/53 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/74 | (2013.01) | ||
| A61K 39/3955 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/507 | (2013.01) | ||
| A61P 1/02 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61K 39/0011 | (2013.01) |
| (11) | Patento numeris | 3230319 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15808464.0 |
| Europos patento paraiškos padavimo data | 2015-12-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-09-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/059268 |
| Data | 2015-12-02 |
| (87) | Numeris | WO 2016/092419 |
| Data | 2016-06-16 |
| (30) | Numeris | Data | Šalis |
| 201462089658 P | 2014-12-09 | US | |
| 201562242750 P | 2015-10-16 | US | |
| 201562251973 P | 2015-11-06 | US |
| (72) |
ABDICHE, Yasmina Noubia , US
CHO, Helen Kim , US
HO, Weihsien , US
JOOSS, Karin Ute , US
RAJPAL, Arvind , US
YOUSSEF, Sawsan , US
|
| (73) |
Rinat Neuroscience Corp. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF |